A detailed history of Clarius Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clarius Group, LLC holds 26,497 shares of PFE stock, worth $708,529. This represents 0.05% of its overall portfolio holdings.

Number of Shares
26,497
Previous 28,697 7.67%
Holding current value
$708,529
Previous $802,000 4.49%
% of portfolio
0.05%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$27.7 - $31.39 $60,940 - $69,058
-2,200 Reduced 7.67%
26,497 $766,000
Q2 2024

Jul 11, 2024

SELL
$25.26 - $29.6 $81,539 - $95,548
-3,228 Reduced 10.11%
28,697 $802,000
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $111,585 - $128,136
-4,310 Reduced 11.89%
31,925 $885,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $271,020 - $352,025
-10,372 Reduced 22.25%
36,235 $1.04 Million
Q3 2023

Oct 19, 2023

SELL
$32.09 - $37.51 $342,560 - $400,419
-10,675 Reduced 18.64%
46,607 $1.55 Million
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $31,496 - $36,440
-872 Reduced 1.5%
57,282 $2.1 Million
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $179,815 - $234,093
-4,565 Reduced 7.28%
58,154 $2.37 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $1,878 - $2,452
45 Added 0.07%
62,719 $3.21 Million
Q3 2022

Oct 24, 2022

BUY
$43.76 - $53.42 $243,261 - $296,961
5,559 Added 9.73%
62,674 $2.74 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $156,526 - $185,591
3,364 Added 6.26%
57,115 $3 Million
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $121,770 - $180,503
2,947 Added 5.8%
53,751 $3.17 Million
Q3 2021

Oct 18, 2021

BUY
$39.25 - $50.42 $40,702 - $52,285
1,037 Added 2.08%
50,804 $2.19 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $213,413 - $241,761
5,943 Added 13.56%
49,767 $1.95 Million
Q1 2021

Apr 27, 2021

SELL
$33.49 - $37.77 $242,132 - $273,077
-7,230 Reduced 14.16%
43,824 $1.59 Million
Q4 2020

Jan 15, 2021

BUY
$33.47 - $42.56 $350,430 - $445,603
10,470 Added 25.8%
51,054 $1.88 Million
Q3 2020

Oct 09, 2020

SELL
$31.75 - $37.25 $14,128 - $16,576
-445 Reduced 1.08%
40,584 $1.49 Million
Q2 2020

Jul 08, 2020

BUY
$30.12 - $36.54 $41,625 - $50,498
1,382 Added 3.49%
41,029 $1.34 Million
Q1 2020

Apr 24, 2020

BUY
$27.03 - $38.62 $72,359 - $103,385
2,677 Added 7.24%
39,647 $1.29 Million
Q4 2019

Jan 22, 2020

BUY
$32.92 - $37.36 $6,946 - $7,882
211 Added 0.57%
36,970 $1.5 Million
Q3 2019

Oct 23, 2019

BUY
$32.49 - $42.13 $290,655 - $376,894
8,946 Added 32.16%
36,759 $1.32 Million
Q2 2019

Aug 02, 2019

SELL
$36.98 - $41.52 $109,312 - $122,733
-2,956 Reduced 9.61%
27,813 $1.21 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $490,500 - $538,896
13,080 Added 73.94%
30,769 $1.31 Million
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $173,268 - $197,545
4,504 Added 34.16%
17,689 $772,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $454,486 - $551,264
13,185 New
13,185 $581,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.